Renovare Environmental (RENO) 10-Q 14 Nov 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 10, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Entity Registrant Name	BIOHITECH GLOBAL, INC.
Entity Central Index Key	1,590,383
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	BHTG
Entity Common Stock, Shares Outstanding		9,598,208

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenue
Rental, service and maintenance	$ 415,402	$ 358,625	$ 1,140,751	$ 996,179
Equipment sales	240,945	264,953	655,493	541,407
Total revenue	656,347	623,578	1,796,244	1,537,586
Cost of revenue
Rental, service and maintenance	348,862	256,107	880,559	761,834
Equipment sales	151,998	176,511	391,152	380,684
Total Cost of revenue	500,860	432,618	1,271,711	1,142,518
Gross profit	155,487	190,960	524,533	395,068
Operating expenses
Selling, general and administrative	1,090,003	983,725	3,211,855	3,171,973
Research and development	207,258	242,435	611,582	661,529
Professional fees	604,225	356,652	1,618,076	894,386
Depreciation and amortization	27,674	29,174	85,781	84,122
Total operating expenses	1,929,160	1,611,986	5,527,294	4,812,010
Loss from operations	(1,773,673)	(1,421,026)	(5,002,761)	(4,416,942)
Other expense (income)
Equity loss in affiliate	5,922	0	11,838	0
Loss on change in fair value of warrants	0	0	1,999	0
Interest income	(712)	0	(713)	(3,068)
Interest expense	528,608	222,142	1,199,040	556,867
Total other expense, net	533,818	222,142	1,212,164	553,799
Net loss	(2,307,491)	(1,643,168)	(6,214,925)	(4,970,741)
Other comprehensive (loss) income
Foreign currency translation adjustment	(15,891)	4,098	(44,395)	10,498
Comprehensive loss	$ (2,323,382)	$ (1,639,070)	$ (6,259,320)	$ (4,960,243)
Net loss per share - basic and diluted	$ (0.27)	$ (0.20)	$ (0.75)	$ (0.60)
Weighted average number of common shares outstanding - basic and diluted	8,397,191	8,229,712	8,316,943	8,229,712

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current Assets
Cash	$ 480,329	$ 325,987
Accounts receivable, net	234,669	140,130
Inventory	346,160	706,017
Prepaid expenses and other current assets	101,093	21,865
Total Current Assets	1,162,251	1,193,999
Equipment on operating leases, net	1,255,409	1,023,404
Equipment, fixtures and vehicles, net	45,096	54,356
Intangible assets, net	196,683	267,042
Investment in Entsorga West Virginia, LLC	1,022,190	0
MBT facility development costs	139,313	0
Other assets	23,500	13,500
Total Assets	3,844,442	2,552,301
Current Liabilities:
Line of credit	2,463,736	2,463,736
Accounts payable	921,129	1,197,277
Accrued expenses	624,856	522,727
Accrued interest	925,790	411,917
Deferred revenue	109,183	61,879
Notes payable, including related party of $275,000	0	375,000
Convertible note, net of deferred financing cost of $6,320 and discounts of $22,648	191,032	0
Convertible notes, including related party of $450,000, net of discounts of $310,814	939,186	0
Advance from related party	544,777	1,213,027
Customer deposits	87,830	36,131
Long-term debt, current portion	6,282	8,525
Total Current Liabilities	6,813,801	6,290,219
Promissory note, related party	4,500,000	2,500,000
Long-term debt, net of current portion	6,922	11,048
Notes payable, including related party of $275,000	375,000	0
Accrued interest, payable in cash or common stock	615,468	253,000
Unsecured subordinated mandatorily convertible notes, including related parties of $4,625,000 and $3,800,000, net of deferred financing costs of $51,539 and $118,866 as of September 30, 2017 and December 31, 2016, respectively	7,673,461	4,956,134
Total Liabilities	19,984,652	14,010,401
Commitments and Contingencies
Stockholders' Deficit
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued	0	0
Common stock, $0.0001 par value, 50,000,000 shares authorized, 8,446,849 shares issued and outstanding as of September 30, 2017; 20,000,000 shares authorized, 8,229,712 shares issued and outstanding as of December 31, 2016	845	823
Additional paid in capital	11,181,512	9,604,324
Accumulated deficit	(27,287,091)	(21,072,166)
Accumulated other comprehensive (loss) gain	(35,476)	8,919
Total Stockholders' Deficit	(16,140,210)	(11,458,100)
Total Liabilities and Stockholders' Deficit	$ 3,844,442	$ 2,552,301

Condensed Consolidated Balance4

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	20,000,000
Common stock, shares issued	8,446,849	8,229,712
Common stock, shares outstanding	8,446,849	8,229,712
Notes Payable, Related Parties, Noncurrent	$ 4,500,000	$ 2,500,000
Notes Payable, Related Parties, Current	275,000	275,000
Convertible Notes Payable [Member]
Debt Instrument, Unamortized Discount, Current	310,814
Notes Payable, Related Parties, Current	450,000
Unsecured Subordinated Convertible Notes [Member]
Due to Related Parties, Noncurrent	4,625,000	3,800,000
Debt Issuance Costs, Noncurrent, Net	51,539	$ 118,866
Convertible Notes [Member]
Debt Instrument, Unamortized Discount, Current	22,648
Debt Issuance Costs, Current, Net	$ 6,320

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss:	$ (6,214,925)	$ (4,970,741)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	299,021	331,807
Provision for bad debts	89,630	70,467
Stock based employee compensation	375,508	512,318
Fees paid in stock and warrants	871,531	0
Interest resulting from amortization of financing costs and discounts	223,718	55,076
Equity loss in affiliate	11,838	0
Change in fair value of warrant liability	1,999	0
Changes in operating assets and liabilities	505,650	343,326
Net cash used in operations	(3,836,030)	(3,657,747)
Cash flow from investing activities:
Sale of used machinery and equipment	13,530	0
Investment in Entsorga West Virginia, LLC	(1,034,028)	0
Increase in MBT facility development costs	(139,313)	0
Purchases of equipment, fixtures and vehicles	(6,057)	(3,825)
Net cash used in investing activities	(1,165,868)	(3,825)
Cash flows from financing activities:
Net change in line of credit	0	(25,017)
Proceeds from convertible notes with warrants and beneficial conversion feature	200,000	0
Proceeds from series convertible notes with warrants and beneficial conversion feature	2,259,000	3,400,000
Deferred financing costs incurred	(23,000)	(165,230)
Repayments of long-term debt	(6,369)	(6,170)
Net cash provided by financing activities	5,137,360	3,733,583
Effect of exchange rate on cash	18,880	64,897
Net change in cash	154,342	136,908
Cash - beginning of period	325,987	39,195
Cash - end of period	480,329	176,103
Promissory Notes [Member]
Cash flows from financing activities:
Proceeds from promissory notes	786,973	526,973
Repayments of promissory notes	0	(200,000)
Convertible Notes [Member]
Cash flows from financing activities:
Proceeds from promissory notes	800,000	0
Advances [Member]
Cash flows from financing activities:
Net increase (decrease) in advances	$ 1,120,756	$ 203,027

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Stockholders' Deficit - 9 months ended Sep. 30, 2017 - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2016	$ (11,458,100)	$ 823	$ 9,604,324	$ 8,919	$ (21,072,166)
Balance (in shares) at Dec. 31, 2016		8,229,712
Share-based employee and director compensation	375,508	$ 0	375,508	0	0
Share-based professional services compensation	873,530	$ 14	873,516	0	0
Share-based professional services compensation (in shares)		133,000
Warrants in connection with debt issuance	183,987	$ 0	183,987	0	0
Beneficial conversion feature of debt	144,185	0	144,185	0	0
Exercise of warrants	0	$ 8	(8)	0	0
Exercise of warrants (in shares)		84,137
Foreign currency translation adjustment	(44,395)	$ 0	0	(44,395)	0
Net loss	(6,214,925)	0	0	0	(6,214,925)
Balance at Sep. 30, 2017	$ (16,140,210)	$ 845	$ 11,181,512	$ (35,476)	$ (27,287,091)
Balance (in shares) at Sep. 30, 2017		8,446,849

Basis of Presentation and Going

Basis of Presentation and Going Concern	9 Months Ended
	Sep. 30, 2017
Basis Of Presentation And Going Concern [Abstract]
Basis Of Presentation And Going Concern Disclosure [Text Block]	Note 1. Basis of Presentation and Going Concern Nature of Operations Basis of Presentation — The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s financial statements for the year ended December 31, 2016, which contains the audited financial statements and notes thereto, for the years ended December 31, 2016 and 2015 included within the Company’s Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 30, 2017. The financial information as of December 31, 2016 presented hereto is derived from the audited consolidated financial statements presented in the Company’s audited consolidated financial statements for the year ended December 31, 2016. The interim results for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for any future interim periods. Reclassifications to certain prior period amounts have been made to conform to current period presentation. These reclassifications have no effect on previously reported net loss. Going Concern — 6,214,925 5,002,761 3,836,030 6,745,386 5,924,667 5,181,400 16,140,210 5,651,550 The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management's further implementation of the Company’s on-going and strategic plans, which include continuing to raise funds through debt and/or equity raises. Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification. The Company is presently in the process of raising additional non-registered preferred stock, senior debt, convertible debt and capital for general operations and for investment in several strategic initiatives, as well as commercial debt to support its leasing activities. There is no assurance that the Company will be able to raise sufficient debt or capital to sustain operations or to pursue other strategic initiatives.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2. Summary of Significant Accounting Policies — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including goodwill and intangibles, and useful lives, employee benefits, taxes and other provisions and contingencies. — The Company recognizes revenue for the majority of its products sold upon transfer of title and the passage of the risk of ownership, which is generally upon shipment to the customer. Revenue from services is recognized as services are performed. — The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its digester units qualify as operating leases, for which the Company is the operating lessor. — Certain assets and liabilities are required to be recorded at fair value on a recurring basis. Fair value is determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets measured at fair value on a nonrecurring basis include long-lived assets held and used, long-lived assets held for sale, goodwill and other intangible assets. The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The three-tier value hierarchy, which prioritizes valuation methodologies based on the reliability of the inputs, is: Level 1 — Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 — Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 — Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. — The Company utilizes the equity method of accounting for investments in companies if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of net income or loss is included in the Company’s consolidated operations as earning or loss from unconsolidated equity basis investments. — Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. For the nine and three months ended September 30, 2017 and 2016, the Company’s effective rate, before valuations, was 39.8 36.7 0.0 — The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” The Company’s potential dilutive instruments include options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Accounts Receivable, net

Accounts Receivable, net	9 Months Ended
	Sep. 30, 2017
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 3. Accounts Receivable, net September 30, December 31, 2017 2016 Accounts receivable $ 353,541 $ 206,219 Less: allowance for doubtful accounts receivable (118,872) (66,089) $ 234,669 $ 140,130

Inventory

Inventory	9 Months Ended
	Sep. 30, 2017
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	Note 4. Inventory September 30, December 31, 2017 2016 Equipment $ 89,187 $ 191,240 Parts and assemblies 256,973 514,777 $ 346,160 $ 706,017

Equipment on Operating Leases,

Equipment on Operating Leases, net	9 Months Ended
	Sep. 30, 2017
Equipment on Operating leases [Abstract]
Capital Leases in Financial Statements of Lessor Disclosure [Text Block]	Note 5. Equipment on Operating Leases, net September 30, December 31, 2017 2016 Leased equipment $ 2,308,317 $ 1,870,569 Less: accumulated depreciation (1,052,908) (847,165) $ 1,255,409 $ 1,023,404 During the three months ended September 30, 2017 and 2016, depreciation expense included in cost of revenue, amounted to $ 69,312 97,356 213,268 247,685 The Company is a lessor of Revolution and Eco Safe Series digester units under non-cancellable operating lease agreements expiring through December 2022. During the three months ended September 30, 2017 and 2016, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $ 224,828 182,715 636,406 505,877 Year Ending December 31, 2017(remaining period) $ 245,184 2018 839,675 2019 709,112 2020 508,268 2021 and thereafter 315,908 Total minimum lease income $ 2,618,147

Equipment, Fixtures and Vehicle

Equipment, Fixtures and Vehicles, net	9 Months Ended
	Sep. 30, 2017
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 6. Equipment, Fixtures and Vehicles, net September 30, December 31, 2017 2016 Computer software and hardware $ 99,705 $ 93,543 Furniture and fixtures 48,196 48,196 Vehicles 69,253 69,253 217,154 210,992 Less: accumulated depreciation and amortization (172,058) (156,636) $ 45,096 $ 54,356 During the three months ended September 30, 2017 and 2016, depreciation expense amounted to $ 5,124 4,675 15,422 10,625

Investment in Entsorga West Vir

Investment in Entsorga West Virginia LLC (“EWV”)	9 Months Ended
	Sep. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments and Joint Ventures Disclosure [Text Block]	Note 7. Investment in Entsorga West Virginia LLC (“EWV”) Effective January 1, 2017, the Company executed several agreements to acquire up to approximately a 40 60,000 1,034,028 17.2 23.1 1,034,028 17.2 (Unaudited) June 30, Balance Sheet 2017 (a) Current assets - cash $ 4,085 Non-current assets: Restricted cash 16,127,778 Facility under development and construction 13,168,100 Total Assets $ 29,299,963 Current liabilities $ 591,608 Non-current liabilities - Tax-exempt bonds, net of $1,616,131 of issuance costs 23,511,677 Membership equity 5,196,678 $ 29,299,963 Six Months ended Statement of Operations June 30, 2017 Revenue $ - Operating expenses 35,156 Loss from operations (35,156) Interest expense 33,669 Net loss $ (68,825) Net loss attributable to BioHiTech Global, Inc. (17.2%) $ (11,838) (a.) The Company utilizes a three-month lag in reporting its share of equity income or loss in EWV. EWV has financed the development and construction of the facility through $ 25,000,000

MBT Facility Development Costs

MBT Facility Development Costs	9 Months Ended
	Sep. 30, 2017
Facility development [Abstract]
Facility development [Text Block]	Note 8. MBT Facility Development Costs On March 1, 2017 the Town Counsel of New Windsor, NY approved, subject to a 30 day petition period during which certain voters could object to the sale of 12 acres of property to the Company for the development of a Mechanical Biological Treatment (“MBT”) facility. On April 3, 2017, the Town Clerk of New Windsor certified that there had not been any objections raised and the agreement was executed on April 10, 2017. The purchase price of the property is $ 1,092,000 3,500 6,000 As of September 30, 2017, the consolidated financial statements include capitalized costs related to the New Windsor, NY site, including those related to the land option payments, legal costs and survey/engineering costs of $ 42,000 10,372 86,941

Intangibles Assets, net

Intangibles Assets, net	9 Months Ended
	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Note 9. Intangibles Assets, net Remaining Useful Weighted Gross Lives Average Carrying Accumulated Net Carrying (Years) Life (Years) Amount Amortization Amount September 30, 2017: Distribution agreements 10 2.2 $ 902,000 $ (705,317) $ 196,683 Website 3 - 23,388 (23,388) - Intangible assets, net $ 925,388 $ (728,705) $ 196,683 December 31, 2016: Distribution agreements 10 2.8 $ 902,000 $ (637,667) $ 264,333 Website 3 0.3 23,388 (20,679) 2,709 Intangible assets, net $ 925,388 $ (658,346) $ 267,042 During the three months ended September 30, 2017 and 2016, amortization expense, included in depreciation and amortization of operating expenses, amounted to $ 22,550 24,499 70,359 73,497 Year Ending December 31, 2017 (Remaining period) $ 22,550 2018 90,200 2019 43,533 2020 20,200 2021 20,200 Total $ 196,683

Risk Concentrations

Risk Concentrations	9 Months Ended
	Sep. 30, 2017
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	Note 10. Risk Concentrations The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. United States International Total 2017: Revenue, for the nine months ended September 30, 2017 $ 1,421,711 $ 374,533 $ 1,796,244 Revenue, for the three months ended September 30, 2017 $ 528,370 $ 127,977 $ 656,347 Non-current tangible assets, as of September 30, 2017 $ 1,198,100 $ 125,904 $ 1,324,004 2016: Revenue, for the nine months ended September 30, 2016 $ 1,224,809 $ 312,777 $ 1,537,586 Revenue, for the three months ended September 30, 2016 $ 469,419 $ 154,159 $ 623,578 Non-current tangible assets, as of December 31, 2016 $ 1,019,664 $ 71,596 $ 1,091,260 Major customers - During the three months ended September 30, 2017, two customers represented at least 10% of revenues, each accounting for 12 11 As of September 30, 2017, one customer represented at least 10% of accounts receivable, accounting for 11 22 10 Vendor concentrations - During the three months ended September 30, 2017, two vendors represented at least 10% of costs of revenue, accounting for 23 1.9 11 18 1.9 11 26 16 10 11 43 10 19 10 As of September 30, 2017, two vendors represented at least 10% of accounts payable, accounting for 27 19 10 32 1.9 21

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 11. Related Party Transactions Related parties include Directors, Senior Management Officers, and shareholders, plus their immediate family, who own a 5 September 30, December 31, 2017 2016 Assets: Intangible assets, net (a) $ 196,683 $ 264,333 Liabilities: Accounts payable 235,841 85,374 Accrued interest payable 840,850 390,812 Long term accrued interest 479,391 187,667 Notes payable 275,000 275,000 Advance from related party (b) 544,777 1,213,027 Promissory note - related parties (c) 4,500,000 2,500,000 Series A - Unsecured subordinated convertible notes (d) 2,250,000 2,250,000 Series B - Unsecured subordinated convertible notes (e) 1,750,000 1,250,000 Series C - Convertible notes (face value) (f) 450,000 - Series D - Unsecured subordinated convertible notes (g) 325,000 - Series V - Unsecured subordinated convertible notes (h) 300,000 300,000 Other: Line of credit guarantee (i) 2,463,736 2,463,736 The table below presents direct related party expenses or transactions for the periods indicated. Compensation and related costs for employees of the Company are excluded from the table below. Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Consulting revenue (j) $ 18,526 $ - $ 53,180 $ - S, G & A - Rent expense (k) 13,511 13,050 40,002 39,150 Cost of revenues – Rent expense (k) 11,027 10,650 32,646 31,950 S, G & A - Consulting expense (a) 50,000 50,000 150,000 150,000 Interest expense 272,250 144,072 745,571 380,481 Cost of revenue, inventory or equipment on operating leases acquired (a and l) 2,822 4,552 9,003 447,952 (a.) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties. (b.) Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13 (c.) Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $ 1,000,000 4,500,000 13 7,500,000 5,000,000 (d.) Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering. (e.) Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016 and 2017, certain related parties participated in such offering. (f.) Series C Convertible Notes and Warrants - In connection with the Company’s issuance of convertible notes and warrants in 2017, the Chief Executive Officer participated in such offering. (g.) Series D Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2017, certain related parties participated in such offering. (h.) Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of unsecured subordinated convertible notes in 2016, BioHiTech International, see note a, above, exchanged $ 300,000 (i.) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line . (j.) Consulting Revenue – The Company provides environmental and project management consulting to Entsorga West Virginia LLC, an entity that the Company accounts for as an equity investment effective March 2017. (k.) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Year Ending December 31, 2017 (Remaining period) $ 24,417 2018 98,524 2019 100,003 2020 41,926 Total $ 264,870 (l.) Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9

Debt

Debt	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	September 30, 2017 December 31, 2016 Net Related Net Related Total Party* Total Party* Line of credit $ 2,463,736 $ - $ 2,463,736 $ - Unsecured subordinated mandatorily convertible notes: Series A 3,383,952 2,250,000 3,310,500 2,250,000 Series B 1,870,634 1,750,000 1,220,634 1,250,000 Series D 1,993,875 325,000 - - Series V 425,000 300,000 425,000 300,000 Convertible note 191,032 - - - Convertible note – Series C 939,186 450,000 - - Promissory note - related party 4,500,000 4,500,000 2,500,000 2,500,000 Notes payable 375,000 275,000 375,000 275,000 Advances 544,777 544,777 1,213,027 1,213,027 Long term debt - other, current and long term portion 13,204 - 19,573 - *Related party debt is presented at mature face value. Series B Unsecured Subordinated Convertible Promissory Notes – During the fourth quarter of 2016 and the first quarter of 2017, the Company entered into a series of Securities Purchase Agreements (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to sell and the Investors agreed to purchase in a private placement offering (the “Private Placement”) units (the “Units”) in the aggregate offering amount of $ 650,000 500,000 Convertible Note – Effective March 30, 2017 the Company entered into a Securities Purchase Agreement, a Convertible Note with a maximum funding amount of $ 550,000 100,000 110,000 4,014 24,750 16,043 2.954 4.00 31.43 2.88 5 100,000 220,000 100,000 1,930 24,750 16,360 2.98 4.00 31.43 2.88 5 The note allows for fundings representing up to $ 550,000 9.5 220,000 2.85 65 During the third quarter of 2017, the holder exercised 24,750 14,093 24,750 4.00 Series C Convertible Notes and Warrants - From May 24, 2017 through August 11, 2017, the Company entered into a series of Securities Purchase Agreements (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to sell and the Investors agreed to purchase units (the “Units”) in the aggregate offering amount of $ 1,250,000 640,000 190,000 100,000 3.5 10 3.00 50 3.75 20 As of September 30, 2017, the Notes reflect: face amount of $ 1,250,000 125,000 151,584 138,240 104,010 208,334 3.05 7.50 3.75 31.1 33.2 2.62 2.79 5 Series D Convertible Notes and Warrants – During the third quarter of 2017, the Company entered into a series of Securities Purchase Agreements (the “Purchase Agreement”) with twenty one accredited investors (the “Investors”), pursuant to which the Company agreed to sell and the Investors agreed to purchase units (the “Units”) in the aggregate offering amount of $ 2,000,000 140,000 325,000 0.0001 July 6, 2019 2.75 The embedded conversion feature and warrants issued in the transaction are not indexed to the Company’s common stock. However, the embedded conversion feature and warrants did not meet the definition of a derivative and therefore such conversion feature was not bifurcated from the underlying note payable and the warrants were not recorded as a derivative liability. as of September 30, 2017, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non-Amortizing Non- Optionally Mandatorily Year Ending December 31, Amortizing Amortizing* Convertible* Convertible* Total 2017 (Remaining period) $ 2,157 $ - $ 110,000 $ - $ 112,157 2018 5,410 - 1,360,000 5,725,000 7,090,410 2019 5,199 4,500,000 - 2,000,000 6.505,199 2020 438 375,000 - - 375,438 Total $ 13,204 $ 4,875,000 $ 1,470,000 $ 7,725,000 $ 14,083,204 * Certain non-amortizing notes are subject to earlier event based maturities. The table above presents all non-amortizing notes at their time period based maturity condition. Interest Expense - All interest on the Company’s various debts, including coupon and amortization of discounts and deferred financing costs are recognized as interest expense in the accompanying consolidated financial statements.

Equity Transactions

Equity Transactions	9 Months Ended
	Sep. 30, 2017
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	Note 13. Equity Transactions Shareholder Information and Marketing Agreement During 2016, the Company entered into a service agreement for an initial three-month term, subject to a termination option after the initial 30-day period. In addition to monthly cash fees, the Company will issue 8,000 3,200 8,053 4,800 12,952 8,000 Shareholder Awareness Consulting Agreement During 2017, the Company entered into a ninety-day consulting agreement for shareholder awareness. The contract provided for 100,000 89,063 267,094 10,937 35,274 100,000 105,188 3.00 2.75 31.11 2.75 5 in a $ 1,999 During the third quarter of 2017, the Company and the consultant agreed to new terms to extend the contract through December 31, 2017. Under the terms of the extension, in addition to cash fees, the Company agreed to grant the consultant an additional 75,000 34,884 102,670 40,116 233,508 During the second quarter of 2017, the Company issued 100,000 100,000 70,044 Series A and B Warrants – In connection with the issuance of Series A, B and D units, which included convertible debt and warrants that are exercisable for a period of five years into shares of common stock equal to the number of shares of common stock into which the notes are convertible at an exercise price equal to 120 Maxim Warrants - In connection with the issuance of the Series A Units, the Company agreed to issue warrants to Maxim Group LLC, the placement agent, that are exercisable into 10 3.75 5 Barksdale Warrants - In connection with an Offering in October 2013 the Company agreed to issue Barksdale Global Holdings, LLC (“Barksdale”) warrants. These warrants were issued on June 30, 2015 to purchase up to $ 140,000 5.0 Other Warrants - In connection with prior debt offerings that have been converted into equity, warrants expiring between May and July of 2020 representing an $80,000 purchase equity interest remain outstanding. The warrants allow the holders to acquire up to $80,000 of the Company’s common stock at a price of 120% of the closing price of the Company’s first issuance of equity in one, or a series of related transactions, through which the Company receives gross proceeds of $5.0 million or more from one or more financial institutions or accredited investors. If the Company does not consummate a Qualified Financing prior to the expiration date, the warrant shall never be exercisable.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 14. Equity Incentive Plans During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000 371,250 347,500 86,596 Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Stock options $ 29,221 $ 34,790 $ 76,218 $ 209,655 Restricted stock units 115,306 126,895 299,290 302,663 $ 144,527 $ 161,685 $ 375,508 $ 512,318 Weighted Average Weighted Remaining Total Number of Average Contractual Aggregate Number of Exercisable Exercise Life Intrinsic Options Options Price (in Years) Value Outstanding at December 31, 2016 363,750 90,418 $ 3.75 8.42 - Granted or vested 79,091 $ 3.75 8.42 - Exercised - - - Forfeited, expired or canceled (37,291) (11,805) 3.75 - - Outstanding at September 30, 2017 326,459 157,704 $ 3.75 8.42 $ 894,498 Number of Shares Unvested balance at December 31, 2016 331,667 Granted - Vested (75,000) Forfeited or Canceled (10,555) Unvested balance at September 30, 2017 246,112 At the Annual Shareholders Meeting on June 7, 2017 the shareholders approved the 2017 Executive Incentive Plan that allows for the granting of awards for up to 1,000,000

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 15. Commitments and Contingencies From time to time, the Company is involved in legal matters arising in the ordinary course of business, including matters that relate to items for which the Company has accrued their contractual obligations, but are disputing payment for. The Company has one such matter relating to a professional services agreement in litigation that it believes does not present a material risk to the Company. While the Company believes that these such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.

Operating Leases

Operating Leases	9 Months Ended
	Sep. 30, 2017
Leases, Operating [Abstract]
Operating Leases of Lessor Disclosure [Text Block]	Note 16. Operating Leases The Company rents its headquarters and attached warehousing space from a related party (see Note 11) and their research and development office from an unrelated party under operating leases. The research and development office lease commenced in October 2015 and will expire in 2018 Year Ending December 31, 2017 (Remaining period) 30,146 2018 115,710 2019 100,003 2020 41,926 Total $ 287,785 Total rent expense under all operating leases amounted to $ 39,921 31,645 105,702 101,078

Supplemental Consolidated State

Supplemental Consolidated Statement of Cash Flows Information	9 Months Ended
	Sep. 30, 2017
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash Flow, Supplemental Disclosures [Text Block]	Note 17. Supplemental Consolidated Statement of Cash Flows Information Nine Months Ended September 30, 2017 2016 Cash flows of operating assets and liabilities: Accounts and note receivable $ (182,297) $ 96,768 Inventory (78,634) (714,298) Prepaid expenses and other assets (88,924) 24,938 Accounts payable (138,665) 367,478 Accrued interest payable 876,342 420,113 Accrued expenses 26,041 28,483 Deferred revenue 42,496 58,077 Customer deposits 49,291 61,767 Net cash flows of operating assets and liabilities $ 505,650 $ 343,326 Supplementary cash flow information: Cash paid during the year for: Interest $ 84,784 $ 81,206 Income taxes - Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 449,951 $ 373,891 Series V Notes issued for consulting services - 25,000 Accrued interest added to principle of promissory note - related party - 263,027 Conversion of advances from related party to promissory notes 1,789,006 - In-Kind payments by investors for Series notes 140,000 -

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	Note 18. Recent Accounting Pronouncements During the nine months ended September 30, 2017, the Company implemented the following recent accounting pronouncements: Stock Compensation - In March 2016, FASB issued ASU No. 2016-09, “Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting” (Topic 718). The amendments in this ASU is to significantly reduce the complexity and cost of accounting for excess tax benefits and tax deficiencies related to employee share-based payment transactions, which include restricted stock and stock options. Also, ASU No. 2016-09 requires an entity to run excess tax benefits and deficiencies through its income statement, which in effect eliminates the concept of additional paid-in capital. This new guidance was implemented during the first quarter of 2017 and its implementation did not have a material impact on the financial statements. Inventory - In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires inventory measured using any method other than last-in, first out (“LIFO”) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. This new guidance was implemented during the first quarter of 2017 and its implementation did not have a material impact on the financial statements. Statement of Cash Flows – In August 2016, the FASB issued Accounting Standards Update No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments Statement of Cash Flows statement of cash flows with the objective of reducing the existing diversity in practice related to eight specific cash flow issues. Accounting for Certain Financial Instruments with Down Round Features - In July 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-11—Earnings Per Share (Topic 260), Distinguishing Liabilities From Equity (Topic 480), and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. ASU 2017-11 eliminates the requirement that a down round feature precludes equity classification when assessing whether an instrument is indexed to an entity’s own stock. A freestanding equity-linked financial instrument no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The effective date for ASU 2017-11 is for annual or any interim periods beginning after December 15, 2018. Early adoption is permitted. The Company implemented this ASU on a retrospectively basis as of January 1, 2017 and April 1, 2017. Since there was no reduction of the conversion price and exercise price of the warrants associated with the Notes, there is no impact upon implementation of ASU 2017-11 to the condensed consolidated financial statements. The Company has not yet implemented the following recent accounting pronouncements: Revenue from Contracts with Customers - In April 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-10, “Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing” (Topic 606). The amendments clarify two aspects of ASU No. 2014-09, “Revenue from Contracts with Customers,” by providing (1) guidance for identifying performance obligations and (2) licensing implementation guidance. Public business entities should apply the guidance similar to Update 2014-09 to annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) ASU No. 2014-09, “Revenue from Contracts with Customers” (ASU 2014-09). ASU 2014-09 provides guidance for revenue recognition and affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. The core principle of ASU 2014-09 is the recognition of revenue when a company transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, companies will need to use more judgment and make more estimates than under the current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09, as amended, is effective for fiscal years beginning after December 15, 2017 and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). The Company does not anticipate that the adoption, by means of a retrospective approach with a cumulative effect, if any, will have a material effect on its consolidated financial position or results of operations. Leases - In February 2016, the FASB issued new lease accounting guidance (ASU No. 2016-02, Leases).

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 19. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. Acquisition of Intellectual Property License for 165,000 ton MBT Facility in development – On November 1, 2017, BioHiTech Global, Inc. and its wholly-owned subsidiary E.N.A. Renewables LLC, entered into a Technology License Agreement (the “License Agreement”) with Entsorgafin S.p.A. (“Entsorga”) whereby the Company acquired a license for the design, development construction, installation and operation of a High Efficiency Biological Treatment (“HEBioT”) renewable waste facility with a capacity of 165,000 tons per year. The patented HEBioT technology converts mixed municipal and organic waste to a US Environmental Protection Agency recognized alternative fuel source. The royalty payment for the license amounted to $ 6,019,200 1,035,905 0.0001 839,678.40 The Company also entered into a Registration Rights Agreement with Entsorga whereby the Company granted Entsorga certain piggy-back and demand registration rights with respect to the Shares. Series A Preferred Stock – On October 30, 2017, the Company entered into a Securities Purchase Agreements (the “Purchase Agreement”) with a single, accredited investor (the “Investor”), pursuant to which the Company agreed to sell and the Investor agreed to purchase up to an aggregate of 333,401 0.0001 1,667,000 1,500,300 333,401 0.0001 5.00 133,334 133,334 600,000 200,067 200,067 900,300 The Series A Shares are convertible into share of Common Stock at the rate of one share of Common Stock for $ 5.00 The Company also granted the Investor certain piggy-back registration rights with respect to the shares of Common Stock underlying the conversion of the Series A Shares and the exercise of the Warrants. Conversion of Debt into Common Stock – During October 2017, Vista Capital Investments LLC converted $ 110,000 40,454 Investor Awareness Contract – Effective October 2, 2017 the Company entered into a new shareholder awareness consulting agreement with its existing consultant. This agreement has a term of 90 days and includes cash fees of $ 90,000 35,000 10,000 5.00

Summary of Significant Accoun26

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Use of Estimates, Policy [Policy Text Block]	Use of Estimates — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including goodwill and intangibles, and useful lives, employee benefits, taxes and other provisions and contingencies.
Revenue Recognition, Policy [Policy Text Block]	Product and Services Revenue Recognition — The Company recognizes revenue for the majority of its products sold upon transfer of title and the passage of the risk of ownership, which is generally upon shipment to the customer. Revenue from services is recognized as services are performed.
Revenue Recognition Leases [Policy Text Block]	Lease Revenue Recognition — The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its digester units qualify as operating leases, for which the Company is the operating lessor.
Fair Value Measurement, Policy [Policy Text Block]	— Certain assets and liabilities are required to be recorded at fair value on a recurring basis. Fair value is determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets measured at fair value on a nonrecurring basis include long-lived assets held and used, long-lived assets held for sale, goodwill and other intangible assets. The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The three-tier value hierarchy, which prioritizes valuation methodologies based on the reliability of the inputs, is: Level 1 — Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 — Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 — Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants.
Equity Method Investments, Policy [Policy Text Block]	Equity Method Based Investments — The Company utilizes the equity method of accounting for investments in companies if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of net income or loss is included in the Company’s consolidated operations as earning or loss from unconsolidated equity basis investments.
Income Tax, Policy [Policy Text Block]	Income Taxes — Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. For the nine and three months ended September 30, 2017 and 2016, the Company’s effective rate, before valuations, was 39.8 36.7 0.0
Earnings Per Share, Policy [Policy Text Block]	Loss per Share — The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” The Company’s potential dilutive instruments include options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Accounts Receivable, net (Table

Accounts Receivable, net (Tables)	9 Months Ended
	Sep. 30, 2017
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	September 30, December 31, 2017 2016 Accounts receivable $ 353,541 $ 206,219 Less: allowance for doubtful accounts receivable (118,872) (66,089) $ 234,669 $ 140,130

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2017
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	September 30, December 31, 2017 2016 Equipment $ 89,187 $ 191,240 Parts and assemblies 256,973 514,777 $ 346,160 $ 706,017

Equipment on Operating Leases29

Equipment on Operating Leases, net (Tables)	9 Months Ended
	Sep. 30, 2017
Equipment on Operating Leases, Net [Abstract]
Schedule of Property Subject to or Available for Operating Lease [Table Text Block]	Equipment on operating leases consist of the following: September 30, December 31, 2017 2016 Leased equipment $ 2,308,317 $ 1,870,569 Less: accumulated depreciation (1,052,908) (847,165) $ 1,255,409 $ 1,023,404
Schedule Of Future Minimum Rental Payments Receivable For Operating Leases [Table Text Block]	The minimum future estimated contractual payments to be received under these leases as of September 30, 2017 is as follows: Year Ending December 31, 2017(remaining period) $ 245,184 2018 839,675 2019 709,112 2020 508,268 2021 and thereafter 315,908 Total minimum lease income $ 2,618,147

Equipment, Fixtures and Vehic30

Equipment, Fixtures and Vehicles, net (Tables)	9 Months Ended
	Sep. 30, 2017
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Equipment, fixtures and vehicles consist of the following: September 30, December 31, 2017 2016 Computer software and hardware $ 99,705 $ 93,543 Furniture and fixtures 48,196 48,196 Vehicles 69,253 69,253 217,154 210,992 Less: accumulated depreciation and amortization (172,058) (156,636) $ 45,096 $ 54,356

Investment in Entsorga West V31

Investment in Entsorga West Virginia LLC (“EWV”) (Tables)	9 Months Ended
	Sep. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments [Table Text Block]	Summarized financial information for EWV is as follows: (Unaudited) June 30, Balance Sheet 2017 (a) Current assets - cash $ 4,085 Non-current assets: Restricted cash 16,127,778 Facility under development and construction 13,168,100 Total Assets $ 29,299,963 Current liabilities $ 591,608 Non-current liabilities - Tax-exempt bonds, net of $1,616,131 of issuance costs 23,511,677 Membership equity 5,196,678 $ 29,299,963 Six Months ended Statement of Operations June 30, 2017 Revenue $ - Operating expenses 35,156 Loss from operations (35,156) Interest expense 33,669 Net loss $ (68,825) Net loss attributable to BioHiTech Global, Inc. (17.2%) $ (11,838) (a.) The Company utilizes a three-month lag in reporting its share of equity income or loss in EWV.

Intangibles Assets, net (Tables

Intangibles Assets, net (Tables)	9 Months Ended
	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	Intangible assets consist of the following: Remaining Useful Weighted Gross Lives Average Carrying Accumulated Net Carrying (Years) Life (Years) Amount Amortization Amount September 30, 2017: Distribution agreements 10 2.2 $ 902,000 $ (705,317) $ 196,683 Website 3 - 23,388 (23,388) - Intangible assets, net $ 925,388 $ (728,705) $ 196,683 December 31, 2016: Distribution agreements 10 2.8 $ 902,000 $ (637,667) $ 264,333 Website 3 0.3 23,388 (20,679) 2,709 Intangible assets, net $ 925,388 $ (658,346) $ 267,042
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	At September 30, 2017, future annual estimated amortization expense is summarized as follows: Year Ending December 31, 2017 (Remaining period) $ 22,550 2018 90,200 2019 43,533 2020 20,200 2021 20,200 Total $ 196,683

Risk Concentrations (Tables)

Risk Concentrations (Tables)	9 Months Ended
	Sep. 30, 2017
Risks and Uncertainties [Abstract]
Revenue from External Customers by Geographic Areas [Table Text Block]	Gross revenues and net non-current tangible assets on a domestic and international basis is as follows: United States International Total 2017: Revenue, for the nine months ended September 30, 2017 $ 1,421,711 $ 374,533 $ 1,796,244 Revenue, for the three months ended September 30, 2017 $ 528,370 $ 127,977 $ 656,347 Non-current tangible assets, as of September 30, 2017 $ 1,198,100 $ 125,904 $ 1,324,004 2016: Revenue, for the nine months ended September 30, 2016 $ 1,224,809 $ 312,777 $ 1,537,586 Revenue, for the three months ended September 30, 2016 $ 469,419 $ 154,159 $ 623,578 Non-current tangible assets, as of December 31, 2016 $ 1,019,664 $ 71,596 $ 1,091,260

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2017
Schedule of Related Party Transactions [Table Text Block]	The table below presents direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. September 30, December 31, 2017 2016 Assets: Intangible assets, net (a) $ 196,683 $ 264,333 Liabilities: Accounts payable 235,841 85,374 Accrued interest payable 840,850 390,812 Long term accrued interest 479,391 187,667 Notes payable 275,000 275,000 Advance from related party (b) 544,777 1,213,027 Promissory note - related parties (c) 4,500,000 2,500,000 Series A - Unsecured subordinated convertible notes (d) 2,250,000 2,250,000 Series B - Unsecured subordinated convertible notes (e) 1,750,000 1,250,000 Series C - Convertible notes (face value) (f) 450,000 - Series D - Unsecured subordinated convertible notes (g) 325,000 - Series V - Unsecured subordinated convertible notes (h) 300,000 300,000 Other: Line of credit guarantee (i) 2,463,736 2,463,736 The table below presents direct related party expenses or transactions for the periods indicated. Compensation and related costs for employees of the Company are excluded from the table below. Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Consulting revenue (j) $ 18,526 $ - $ 53,180 $ - S, G & A - Rent expense (k) 13,511 13,050 40,002 39,150 Cost of revenues – Rent expense (k) 11,027 10,650 32,646 31,950 S, G & A - Consulting expense (a) 50,000 50,000 150,000 150,000 Interest expense 272,250 144,072 745,571 380,481 Cost of revenue, inventory or equipment on operating leases acquired (a and l) 2,822 4,552 9,003 447,952 (a.) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties. (b.) Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13 (c.) Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $ 1,000,000 4,500,000 13 7,500,000 5,000,000 (d.) Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering. (e.) Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016 and 2017, certain related parties participated in such offering. (f.) Series C Convertible Notes and Warrants - In connection with the Company’s issuance of convertible notes and warrants in 2017, the Chief Executive Officer participated in such offering. (g.) Series D Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2017, certain related parties participated in such offering. (h.) Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of unsecured subordinated convertible notes in 2016, BioHiTech International, see note a, above, exchanged $ 300,000 (i.) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line . (j.) Consulting Revenue – The Company provides environmental and project management consulting to Entsorga West Virginia LLC, an entity that the Company accounts for as an equity investment effective March 2017. (k.) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period.
Facility Lease [Member]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum lease payments as of September 30, 2017 under these operating leases are: Year Ending December 31, 2017 (Remaining period) $ 24,417 2018 98,524 2019 100,003 2020 41,926 Total $ 264,870

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2017
Debt Instruments [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	Notes, lines, advances and long term debts are comprised of the following: September 30, 2017 December 31, 2016 Net Related Net Related Total Party* Total Party* Line of credit $ 2,463,736 $ - $ 2,463,736 $ - Unsecured subordinated mandatorily convertible notes: Series A 3,383,952 2,250,000 3,310,500 2,250,000 Series B 1,870,634 1,750,000 1,220,634 1,250,000 Series D 1,993,875 325,000 - - Series V 425,000 300,000 425,000 300,000 Convertible note 191,032 - - - Convertible note – Series C 939,186 450,000 - - Promissory note - related party 4,500,000 4,500,000 2,500,000 2,500,000 Notes payable 375,000 275,000 375,000 275,000 Advances 544,777 544,777 1,213,027 1,213,027 Long term debt - other, current and long term portion 13,204 - 19,573 - *Related party debt is presented at mature face value.
Schedule of Maturities of Long-term Debt [Table Text Block]	Maturities of Promissory Notes, Convertible Notes, Long Term Debt and Unsecured Subordinated Convertible Notes – as of September 30, 2017, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non-Amortizing Non- Optionally Mandatorily Year Ending December 31, Amortizing Amortizing* Convertible* Convertible* Total 2017 (Remaining period) $ 2,157 $ - $ 110,000 $ - $ 112,157 2018 5,410 - 1,360,000 5,725,000 7,090,410 2019 5,199 4,500,000 - 2,000,000 6.505,199 2020 438 375,000 - - 375,438 Total $ 13,204 $ 4,875,000 $ 1,470,000 $ 7,725,000 $ 14,083,204 * Certain non-amortizing notes are subject to earlier event based maturities. The table above presents all non-amortizing notes at their time period based maturity condition. Interest Expense - All interest on the Company’s various debts, including coupon and amortization of discounts and deferred financing costs are recognized as interest expense in the accompanying consolidated financial statements.

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	Compensation expense related to the options and restricted stock units was: Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Stock options $ 29,221 $ 34,790 $ 76,218 $ 209,655 Restricted stock units 115,306 126,895 299,290 302,663 $ 144,527 $ 161,685 $ 375,508 $ 512,318
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2017: Weighted Average Weighted Remaining Total Number of Average Contractual Aggregate Number of Exercisable Exercise Life Intrinsic Options Options Price (in Years) Value Outstanding at December 31, 2016 363,750 90,418 $ 3.75 8.42 - Granted or vested 79,091 $ 3.75 8.42 - Exercised - - - Forfeited, expired or canceled (37,291) (11,805) 3.75 - - Outstanding at September 30, 2017 326,459 157,704 $ 3.75 8.42 $ 894,498
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	The following table summarizes the Company’s restricted stock unit activity for the nine months ended September 30, 2017: Number of Shares Unvested balance at December 31, 2016 331,667 Granted - Vested (75,000) Forfeited or Canceled (10,555) Unvested balance at September 30, 2017 246,112

Operating Leases (Tables)

Operating Leases (Tables)	9 Months Ended
	Sep. 30, 2017
Research And Development Lease [Member]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	The research and development office lease commenced in October 2015 and will expire in 2018 Year Ending December 31, 2017 (Remaining period) 30,146 2018 115,710 2019 100,003 2020 41,926 Total $ 287,785

Supplemental Consolidated Sta38

Supplemental Consolidated Statement of Cash Flows Information (Tables)	9 Months Ended
	Sep. 30, 2017
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	Cash flows of non-cash operating assets and liabilities, as well as other supplemental disclosures, are as follows: Nine Months Ended September 30, 2017 2016 Cash flows of operating assets and liabilities: Accounts and note receivable $ (182,297) $ 96,768 Inventory (78,634) (714,298) Prepaid expenses and other assets (88,924) 24,938 Accounts payable (138,665) 367,478 Accrued interest payable 876,342 420,113 Accrued expenses 26,041 28,483 Deferred revenue 42,496 58,077 Customer deposits 49,291 61,767 Net cash flows of operating assets and liabilities $ 505,650 $ 343,326 Supplementary cash flow information: Cash paid during the year for: Interest $ 84,784 $ 81,206 Income taxes - Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 449,951 $ 373,891 Series V Notes issued for consulting services - 25,000 Accrued interest added to principle of promissory note - related party - 263,027 Conversion of advances from related party to promissory notes 1,789,006 - In-Kind payments by investors for Series notes 140,000 -

Basis of Presentation and Goi39

Basis of Presentation and Going Concern (Details Textual) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Basis Of Presentation And Going Concern [Line Items]
Net Income (Loss) Attributable to Parent	$ (2,307,491)	$ (1,643,168)	$ (6,214,925)	$ (4,970,741)	$ 6,745,386
Operating Income (Loss), Total	(1,773,673)	$ (1,421,026)	(5,002,761)	(4,416,942)	5,924,667
Net Cash Provided by (Used in) Operating Activities			(3,836,030)	$ (3,657,747)	5,181,400
Working Capital Deficit			5,651,550
Stockholders' Equity Attributable to Parent	$ (16,140,210)		$ (16,140,210)		$ (11,458,100)

Summary of Significant Accoun40

Summary of Significant Accounting Policies (Details Textual)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Summary Of Significant Accounting Policies [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	39.80%	36.70%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	0.00%

Accounts Receivable, net (Detai

Accounts Receivable, net (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Accounts receivable	$ 353,541	$ 206,219
Less: allowance for doubtful accounts receivable	(118,872)	(66,089)
Accounts Receivable, Net, Current, Total	$ 234,669	$ 140,130

Inventory (Details)

Inventory (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Inventory [Line Items]
Inventory, Net, Total	$ 346,160	$ 706,017
Equipment [Member]
Inventory [Line Items]
Inventory, Net, Total	89,187	191,240
Parts and Assemblies [Member]
Inventory [Line Items]
Inventory, Net, Total	$ 256,973	$ 514,777

Equipment on Operating Leases43

Equipment on Operating Leases, net (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Leased equipment	$ 2,308,317	$ 1,870,569
Less: accumulated depreciation	(1,052,908)	(847,165)
Property Subject to or Available for Operating Lease, Net, Total	$ 1,255,409	$ 1,023,404

Equipment on Operating Leases44

Equipment on Operating Leases, net (Details 1)	Sep. 30, 2017USD ($)
2017 (remaining period)	$ 245,184
2,018	839,675
2,019	709,112
2,020	508,268
2021 and thereafter	315,908
Total minimum lease income	$ 2,618,147

Equipment on Operating Leases45

Equipment on Operating Leases, net (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Depreciation	$ 69,312	$ 97,356	$ 213,268	$ 247,685
Operating Leases, Income Statement, Lease Revenue, Total	415,402	358,625	1,140,751	996,179
Eco Safe digester [Member]
Operating Leases, Income Statement, Lease Revenue, Total	$ 224,828	$ 182,715	$ 636,406	$ 505,877

Equipment, Fixtures and Vehic46

Equipment, Fixtures and Vehicles, net (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 217,154	$ 210,992
Less: accumulated depreciation and amortization	(172,058)	(156,636)
Property, Plant and Equipment, Net, Total	45,096	54,356
Computer software and hardware [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	99,705	93,543
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	48,196	48,196
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 69,253	$ 69,253

Equipment, Fixtures and Vehic47

Equipment, Fixtures and Vehicles, net (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total	$ 27,674	$ 29,174	$ 85,781	$ 84,122
Equipment Fixtures And Vechicles [Member]
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total	$ 5,124	$ 4,675	$ 15,422	$ 10,625

Investment in Entsorga West V48

Investment in Entsorga West Virginia LLC (“EWV”) (Details)	Jun. 30, 2017USD ($)	[1]
Current assets - cash	$ 4,085
Non-current assets:
Restricted cash	16,127,778
Facility under development and construction	13,168,100
Total Assets	29,299,963
Current liabilities	591,608
Non-current liabilities - Tax-exempt bonds, net of $1,616,131 of issuance costs	23,511,677
Membership equity	5,196,678
Equity Method Investment, Summarized Financial Information, Liabilities and Equity	$ 29,299,963
[1]	The Company utilizes a three-month lag in reporting its share of equity income or loss in EWV.

Investment in Entsorga West V49

Investment in Entsorga West Virginia LLC (“EWV”) (Details 1) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Revenue			$ 0
Operating expenses			35,156
Loss from operations			(35,156)
Interest expense			33,669
Net loss			(68,825)
Net loss attributable to BioHiTech Global, Inc. (17.2%)	$ (5,922)	$ 0	$ (11,838)	$ (11,838)	$ 0

Investment in Entsorga West V50

Investment in Entsorga West Virginia LLC (“EWV”) (Details Textual) - USD ($)	Sep. 30, 2017	Jun. 30, 2017	Mar. 21, 2017	Jan. 02, 2017	Dec. 31, 2016
Equity Method Investments	$ 1,022,190				$ 0
Unamortized Debt Issuance Expense		$ 1,616,131
Entsorga West Virginia LLC [Member]
Issuance of solid wasted is postal revenue bond	$ 25,000,000
Business Acquisition, Percentage of Voting Interests Acquired			17.20%	17.20%
Business Acquisition, Purchase Price For one Percentage Interest				$ 60,000
Equity Method Investments			$ 1,034,028	$ 1,034,028
Business Acquisition, Remaining Voting Interest To Be Acquired At Company Option				23.10%
Maximum [Member] | Entsorga West Virginia LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired				40.00%

MBT Facility Development Costs

MBT Facility Development Costs (Details Textual) - USD ($)	Apr. 03, 2017	Sep. 30, 2017	Dec. 31, 2016
Land and Land Improvements		$ 139,313	$ 0
Land Option [Member]
Land and Land Improvements		42,000
Legal Cost [Member]
Land and Land Improvements		10,372
Survey Cost [Member]
Land and Land Improvements		$ 86,941
Land [Member]
Payments to Acquire Property, Plant, and Equipment	$ 1,092,000
Monthly Payments For First Twelve Month	3,500
Monthly Payments For Next Twelve Month	$ 6,000

Intangibles Assets, net (Detail

Intangibles Assets, net (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 925,388	$ 925,388
Finite-Lived Intangible Assets, Accumulated Amortization	(728,705)	(658,346)
Finite-Lived Intangible Assets, Net, Total	$ 196,683	$ 267,042
Distribution Rights [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years	10 years
Finite-Lived Intangible Assets, Remaining Amortization Period	2 years 2 months 12 days	2 years 9 months 18 days
Finite-Lived Intangible Assets, Gross	$ 902,000	$ 902,000
Finite-Lived Intangible Assets, Accumulated Amortization	(705,317)	(637,667)
Finite-Lived Intangible Assets, Net, Total	$ 196,683	$ 264,333
Website [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years	3 years
Finite-Lived Intangible Assets, Remaining Amortization Period	0 years	3 months 18 days
Finite-Lived Intangible Assets, Gross	$ 23,388	$ 23,388
Finite-Lived Intangible Assets, Accumulated Amortization	(23,388)	(20,679)
Finite-Lived Intangible Assets, Net, Total	$ 0	$ 2,709

Intangibles Assets, net (Deta53

Intangibles Assets, net (Details 1) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Indefinite-lived Intangible Assets [Line Items]
2017 (Remaining period)	$ 22,550
2,018	90,200
2,019	43,533
2,020	20,200
2,021	20,200
Total	$ 196,683	$ 267,042

Intangibles Assets, net (Deta54

Intangibles Assets, net (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Indefinite-lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 22,550	$ 24,499	$ 70,359	$ 73,497

Risk Concentrations (Details)

Risk Concentrations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Concentration Risk [Line Items]
Revenue	$ 656,347	$ 623,578	$ 1,796,244	$ 1,537,586
Non-current tangible assets	1,324,004		1,324,004		$ 1,091,260
UNITED STATES
Concentration Risk [Line Items]
Revenue	528,370	469,419	1,421,711	1,224,809
Non-current tangible assets	1,198,100		1,198,100		1,019,664
International [Member]
Concentration Risk [Line Items]
Revenue	127,977	$ 154,159	374,533	$ 312,777
Non-current tangible assets	$ 125,904		$ 125,904		$ 71,596

Risk Concentrations (Details Te

Risk Concentrations (Details Textual)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Sales Revenue, Net [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	12.00%	11.00%
Sales Revenue, Net [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	12.00%	11.00%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			11.00%		22.00%
Accounts Receivable [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage					10.00%
Accounts Payable [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			10.00%		1.90%
Accounts Payable [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			27.00%		32.00%
Accounts Payable [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			19.00%		21.00%
Cost Of Revenue [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	1.90%	10.00%	1.90%	10.00%
Cost Of Revenue [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	23.00%	26.00%	18.00%	43.00%
Cost Of Revenue [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	11.00%	16.00%	11.00%	19.00%
Cost Of Revenue [Member] | Vendor Three [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		11.00%		10.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Assets:
Intangible assets, net		$ 196,683		$ 196,683		$ 267,042
Liabilities:
Accounts payable		921,129		921,129		1,197,277
Accrued interest payable		925,790		925,790		411,917
Long term accrued interest		615,468		615,468		253,000
Notes payable		0		0		375,000
Advance from related party		544,777		544,777		1,213,027
Promissory note - related parties		275,000		275,000		275,000
Other:
Consulting revenue	[1]	18,526	$ 0	53,180	$ 0
S, G & A - Rent expense	[2]	13,511	13,050	40,002	39,150
Cost of revenues - Rent expense	[2]	11,027	10,650	32,646	31,950
S, G & A - Consulting expense	[3]	50,000	50,000	150,000	150,000
Interest expense		272,250	144,072	745,571	380,481
Cost of revenue, inventory or equipment on operating leases acquired	[3],[4]	2,822	$ 4,552	9,003	$ 447,952
Series A Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[5]	2,250,000		2,250,000		2,250,000
Series B Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[6]	1,750,000		1,750,000		1,250,000
Series C Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[7]	450,000		450,000		0
Series D Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[8]	325,000		325,000		0
Series V Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[9]	300,000		300,000		300,000
Related Party [Member]
Assets:
Intangible assets, net	[3]	196,683		196,683		264,333
Liabilities:
Accounts payable		235,841		235,841		85,374
Accrued interest payable		840,850		840,850		390,812
Long term accrued interest		479,391		479,391		187,667
Notes payable		275,000		275,000		275,000
Advance from related party	[10],[11]	544,777		544,777		1,213,027
Promissory note - related parties	[12]	4,500,000		4,500,000		2,500,000
Other:
Line of credit guarantee	[4]	$ 2,463,736		$ 2,463,736		$ 2,463,736
[1]	Consulting Revenue – The Company provides environmental and project management consulting to Entsorga West Virginia LLC, an entity that the Company accounts for as an equity investment effective March 2017.
[2]	Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period.
[3]	Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties.
[4]	Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line.
[5]	Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering.
[6]	Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016 and 2017, certain related parties participated in such offering.
[7]	Series C Convertible Notes and Warrants - In connection with the Company’s issuance of convertible notes and warrants in 2017, the Chief Executive Officer participated in such offering.
[8]	Series D Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2017, certain related parties participated in such offering.
[9]	Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of unsecured subordinated convertible notes in 2016, BioHiTech International, see note a, above, exchanged $300,000 in accounts payable by the Company for a $300,000 note.
[10]	Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.
[11]	Related party debt is presented at mature face value.
[12]	Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $1,000,000 (the “Promissory Note”). This note has been amended most recently effective February 1, 2017. The amended note provides for up to $4,500,000 in borrowings, an interest rate of 13% per annum, which is subject to prospective reduction to 10% upon the Company’s completion of raising $7,500,000 in connection with an offering of unsecured subordinated convertible notes and warrants and is due on the earlier of (a) a change of control, (b) an event of non-payment default, (c) the two-year anniversary of the Promissory Note (February 1, 2019), or (d) a Qualified Financing. For purposes of the Promissory Note, a Qualified Financing is defined as the first issuance of debt or equity by the Company through which the Company received gross proceeds of a minimum of $5,000,000 from one or more financial institutions or accredited investors.

Related Party Transactions (D58

Related Party Transactions (Details 1) - Facility Lease [Member]	Sep. 30, 2017USD ($)
2017 (Remaining period)	$ 24,417
2,018	98,524
2,019	100,003
2,020	41,926
Total	$ 264,870

Related Party Transactions (D59

Related Party Transactions (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2017	Dec. 31, 2016	Jun. 25, 2014
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	5.00%
Unsecured Subordinated Convertible Notes And Warrants Offering	$ 7,500,000
BioHiTech [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent		1.90%
Series V Convertible Notes [Member]
Related Party Transaction [Line Items]
Convertible Subordinated Debt	425,000	$ 425,000
Series V Convertible Notes [Member] | BioHiTech [Member]
Related Party Transaction [Line Items]
Convertible Subordinated Debt	300,000
Amended [Member]
Related Party Transaction [Line Items]
Secured Debt	$ 4,500,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	13.00%
Secured Debt [Member]
Related Party Transaction [Line Items]
Secured Debt			$ 1,000,000
Debt Instrument, Interest Rate, Effective Percentage	13.00%
Proceeds from Issuance of Debt	$ 5,000,000

Debt (Details)

Debt (Details) - USD ($)		Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Line of credit		$ 2,463,736	$ 2,463,736
Convertible notes		191,032	0
Promissory note - related party		4,500,000	2,500,000
Notes payable		375,000	375,000
Advances		544,777	1,213,027
Long term debt - other, current and long term portion		13,204	19,573
Series A Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		3,383,952	3,310,500
Series B ConvertibleNotes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		1,870,634	1,220,634
Series D Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		1,993,875	0
Series V Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		425,000	425,000
Convertible Note Series C [Member]
Debt Instrument [Line Items]
Convertible notes		939,186	0
Related Party [Member]
Debt Instrument [Line Items]
Line of credit	[1]	0	0
Convertible notes	[1]	0	0
Promissory note - related party	[1]	4,500,000	2,500,000
Notes payable	[1]	275,000	275,000
Advances	[1],[2]	544,777	1,213,027
Long term debt - other, current and long term portion	[1]	0	0
Related Party [Member] | Series A Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes	[1]	2,250,000	2,250,000
Related Party [Member] | Series B ConvertibleNotes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes	[1]	1,750,000	1,250,000
Related Party [Member] | Series D Convertible Notes [Member]
Debt Instrument [Line Items]
Convertible notes	[1]	325,000	0
Related Party [Member] | Series V Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes	[1]	300,000	300,000
Related Party [Member] | Convertible Note Series C [Member]
Debt Instrument [Line Items]
Convertible notes	[1]	$ 450,000	$ 0
[1]	Related party debt is presented at mature face value.
[2]	Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.

Debt (Details 1)

Debt (Details 1) - USD ($)		Sep. 30, 2017	Dec. 31, 2016
2017 (Remaining period)		$ 112,157
2,018		7,090,410
2,019		6.505199
2,020		375,438
Total		13,204	$ 19,573
Total		14,083,204
Amortizing [Member]
2017 (Remaining period)		2,157
2,018		5,410
2,019		5,199
2,020		438
Total		13,204
Non-Amortizing [Member]
2017 (Remaining period)	[1]	0
2,018	[1]	0
2,019	[1]	4,500,000
2,020	[1]	375,000
Total	[1]	4,875,000
Optionally Convertible [Member]
2017 (Remaining period)	[1]	110,000
2,018	[1]	1,360,000
2,019	[1]	0
2,020	[1]	0
Total	[1]	1,470,000
Non-Amortizing Mandatorily Convertible [Member]
2017 (Remaining period)	[1]	0
2,018	[1]	5,725,000
2,019	[1]	2,000,000
2,020	[1]	0
Total	[1]	$ 7,725,000
[1]	Certain non-amortizing notes are subject to earlier event based maturities. The table above presents all non-amortizing notes at their time period based maturity condition.

Debt (Details Textual)

Debt (Details Textual) - USD ($)	1 Months Ended			3 Months Ended		9 Months Ended
	Jun. 26, 2017	Jun. 26, 2017	May 24, 2017	Sep. 30, 2017	Mar. 31, 2017	Sep. 30, 2017	Mar. 30, 2017	Dec. 31, 2016
Line of Credit Facility, Maximum Borrowing Capacity							$ 550,000
Debt Instrument, Face Amount	$ 100,000	$ 100,000
Convertible Long Term Notes Payable Related Party	220,000	220,000
Debt Instrument, Interest Rate, Effective Percentage				5.00%		5.00%
Issuance Of Convertible Promissory Notes And Warrants				$ 325,000		$ 325,000
Proceeds from Notes Payable		100,000
Convertible Debt				$ 191,032		$ 191,032		$ 0
Warrants Exercised, Number				24,750
Stock Issued During Period, Shares, Cashless Exercise of Warrants				14,093
Warrant [Member]
Fair Value Assumptions, Exercise Price				$ 3.75		$ 3.75
Fair Value Assumptions, Expected Term						5 years
Amortization of Debt Discount (Premium)						$ 104,010
Chief Executive Officer [Member]
Debt Instrument, Interest Rate, Effective Percentage				13.00%		13.00%
Convertible Debt [Member]
Debt Instrument, Face Amount					$ 110,000
Debt Instrument, Convertible, Conversion Price				$ 2.85		$ 2.85
Warrants and Rights Outstanding					16,043
Debt Instrument, Interest Rate, Effective Percentage				9.50%		9.50%
Proceeds from Notes Payable					$ 100,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				24,750		24,750
Share Price				$ 4	$ 2.954	$ 4
Fair Value Assumptions, Exercise Price					$ 4
Fair Value Assumptions, Expected Volatility Rate					31.43%
Fair Value Assumptions, Risk Free Interest Rate					2.88%
Fair Value Assumptions, Expected Term					5 years
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger						65.00%
Debt Instrument, Convertible, Beneficial Conversion Feature	1,930				$ 4,014
Convertible Debt				$ 220,000		$ 220,000
Convertible Debt [Member] | Convetible Debt Warrants [Member]
Warrants and Rights Outstanding	$ 16,360	$ 16,360
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	24,750	24,750			24,750
Share Price	$ 2.98	$ 2.98
Fair Value Assumptions, Exercise Price	$ 4	$ 4
Fair Value Assumptions, Expected Volatility Rate	31.43%
Fair Value Assumptions, Risk Free Interest Rate	2.88%
Fair Value Assumptions, Expected Term	5 years
Convertible Debt [Member] | Maximum [Member] | Convetible Debt Warrants [Member]
Share Price				$ 7.50		$ 7.50
Fair Value Assumptions, Expected Volatility Rate						33.20%
Fair Value Assumptions, Risk Free Interest Rate						2.79%
Convertible Debt [Member] | Minimum [Member]
Debt Instrument, Face Amount				$ 550,000		$ 550,000
Convertible Debt [Member] | Minimum [Member] | Convetible Debt Warrants [Member]
Share Price				$ 3.05		$ 3.05
Fair Value Assumptions, Expected Volatility Rate						31.10%
Fair Value Assumptions, Risk Free Interest Rate						2.62%
Series B Convertible Notes [Member]
Proceeds from Notes Payable						$ 650,000
Series B Convertible Notes [Member] | Officer or Shareholders [Member]
Proceeds from Notes Payable						500,000
Series C Convertible Notes And Warrants [Member]
Debt Instrument, Face Amount			$ 1,250,000	$ 1,250,000		1,250,000
Debt Instrument, Interest Rate, Stated Percentage			3.50%
Debt Instrument, Convertible, Conversion Price			$ 3
Warrants and Rights Outstanding				$ 151,584		$ 151,584
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				208,334		208,334
Debt Instrument, Convertible, Beneficial Conversion Feature						$ 138,240
Debt Instrument Minimum Subscription Amount			$ 100,000
Debt Instrument, Original Issue Discount Percentage			10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 3.75
Purchase Agreement, Rights to Investor in Financings			20.00%
Class of Warrant, Exercisable to Common Stock Percentage			50.00%
Debt Instrument, Unamortized Discount, Noncurrent				$ 125,000		125,000
Series C Convertible Notes And Warrants [Member] | Chief Executive Officer [Member]
Debt Instrument, Face Amount			$ 640,000
Series C Convertible Notes And Warrants [Member] | Third Party [Member]
Debt Instrument, Face Amount				$ 190,000		$ 190,000
Series D Convertible Notes and Warrants [Member]
Debt Instrument, Convertible, Conversion Price				$ 2.75		$ 2.75
Debt Instrument, Maturity Date				Jul. 6, 2019
Class of Warrant or Right Term						(i) the trading price on the date of the Listing; (ii) the price per share paid by investors in a subsequent underwritten public offering in connection with the Listing; (iii) the lowest price paid by investors in a subsequent offering of the Registrant’s securities; (iv) the per share price in a Change of Control transaction; or (v) $2.75 per share. The Warrants are exercisable for a period of five years into a number of shares of Common Stock equal to the number of shares of Common Stock into which such Investor’s Note is convertible at an exercise price equal to 120% of the Conversion Price.
Debt Instrument, Maturity Date, Description						Each Note bears interest at the rate of 8% per annum and is due on the earlier of: (i) July 6, 2019; (ii) the date the Common Stock is listed on The Nasdaq Stock Market or NYSE MKT (the “Listing”); or (iii) a “Change of Control” of the Registrant which is defined as a liquidation, dissolution, winding up, change in voting control, or sale of all or substantially all of the Registrant’s assets (the “Maturity”).
Issuance Of Unsecured Convertible Notes And Warrants				$ 2,000,000		$ 2,000,000
Issuance Of Unsecured Convertible Notes And Warrants,Payment In Kind				$ 140,000		$ 140,000

Equity Transactions (Details Te

Equity Transactions (Details Textual) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015
Description Of Other Warrants					The warrants allow the holders to acquire up to $80,000 of the Company’s common stock at a price of 120% of the closing price of the Company’s first issuance of equity in one, or a series of related transactions, through which the Company receives gross proceeds of $5.0 million or more from one or more financial institutions or accredited investors.
Fair Value Adjustment of Warrants	$ 0	$ 1,999		$ 0	$ 1,999	$ 0
Stock Issued During Period, Value, Issued for Services					$ 873,530
Warrants Exercised, Number	24,750
Stock Issued During Period, Shares, Cashless Exercise of Warrants	14,093
Shareholder Information and Marketing Agreement [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross		8,000	3,200				4,800
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized							8,000
Stock Issued During Period, Value, Restricted Stock Award, Gross			$ 8,053				$ 12,952
Shareholder Awareness Consulting Agreement [Member]
Fair Value Assumptions, Risk Free Interest Rate		2.75%
Share Price	$ 3				$ 3
Stock Issued During Period, Shares, Restricted Stock Award, Gross		10,937	89,063
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	100,000				100,000
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 35,274	$ 267,094
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	100,000				100,000
Warrants Not Settleable in Cash, Fair Value Disclosure	$ 105,188				$ 105,188
Fair Value Assumptions, Exercise Price	$ 2.75				$ 2.75
Fair Value Assumptions, Expected Volatility Rate		31.11%
Fair Value Assumptions, Expected Term		5 years
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized	75,000
Stock Issued During Period, Shares, Issued for Services	40,116	34,884
Stock Issued During Period, Value, Issued for Services	$ 233,508	$ 102,670
Series A and B Warrants [Member]
Conversion Price of Notes, Percentage	120.00%				120.00%
Maxim Warrants [Member]
Percentage Of Warrants Exercisable Of Common Shares					10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 3.75				$ 3.75
Warrant Expiration Terms					5 years
Barksdale Warrants [Member]
Proceeds from Issuance of Warrants								$ 5,000,000
Warrants To Purchase Of Common Stock								$ 140,000

Equity Incentive Plans (Details

Equity Incentive Plans (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Stock options	$ 29,221	$ 34,790	$ 76,218	$ 209,655
Restricted stock units	115,306	126,895	299,290	302,663
Share-based compensation	$ 144,527	$ 161,685	$ 375,508	$ 512,318

Equity Incentive Plans (Detai65

Equity Incentive Plans (Details 1) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Number of Options, Beginning Balance	363,750
Number of Options, Granted or vested	0
Number of Options, Exercised	0
Number of Options, Forfeited or Canceled	(37,291)
Number of Options, Ending Balance	326,459	363,750
Number of Options, Exercisable, Beginning Balance	90,418
Number of Options, Exercisable, Granted or vested	79,091
Number of Options, Exercisable, Exercised	0
Number of Options, Exercisable, Forfeited or canceled	(11,805)
Number of Options, Exercisable, Ending Balance	157,704	90,418
Weighted Average Exercise Price, Beginning Balance	$ 3.75
Weighted Average Exercise Price, Granted or vested	3.75
Weighted Average Exercise Price, Exercised	0
Weighted Average Exercise Price, Forfeited or Canceled	3.75
Weighted Average Exercise Price, Ending Balance	$ 3.75	$ 3.75
Weighted Average Remaining Contractual Life (in Years), Granted or vested	8 years 5 months 1 day
Weighted Average Remaining Contractual Life (in Years), Outstanding	8 years 5 months 1 day	8 years 5 months 1 day
Aggregate Intrinsic Value, Outstanding	$ 894,498	$ 0

Equity Incentive Plans (Detai66

Equity Incentive Plans (Details 2)	9 Months Ended
	Sep. 30, 2017shares
Unvested balance at December 31, 2016	331,667
Granted	0
Vested	(75,000)
Forfeited or Canceled	(10,555)
Unvested balance at September 30, 2017	246,112

Equity Incentive Plans (Detai67

Equity Incentive Plans (Details Textual) - shares	1 Months Ended	9 Months Ended	12 Months Ended
	Apr. 15, 2016	Sep. 30, 2017	Dec. 31, 2016	Jun. 07, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		0
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	347,500
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			371,250
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		750,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		86,596
Executive Incentive Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized				1,000,000

Operating Leases (Details)

Operating Leases (Details) - Research And Development Lease [Member]	Sep. 30, 2017USD ($)
Operating Leased Assets [Line Items]
2017 (Remaining period)	$ 30,146
2,018	115,710
2,019	100,003
2,020	41,926
Total	$ 287,785

Operating Leases (Details Textu

Operating Leases (Details Textual) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Operating Leased Assets [Line Items]
Operating Leases, Rent Expense	[1]	$ 13,511	$ 13,050	$ 40,002	$ 39,150
Research And Development Lease [Member]
Operating Leased Assets [Line Items]
Operating Lease Expiration Term				2,018
Operating Leases, Rent Expense		$ 39,921	$ 31,645	$ 105,702	$ 101,078
[1]	Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period.

Supplemental Consolidated Sta70

Supplemental Consolidated Statement of Cash Flows Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows of operating assets and liabilities:
Accounts and note receivable	$ (182,297)	$ 96,768
Inventory	(78,634)	(714,298)
Prepaid expenses and other assets	(88,924)	24,938
Accounts payable	(138,665)	367,478
Accrued interest payable	876,342	420,113
Accrued expenses	26,041	28,483
Deferred revenue	42,496	58,077
Customer deposits	49,291	61,767
Net cash flows of operating assets and liabilities	505,650	343,326
Supplementary cash flow information:
Cash paid during the year for: Interest	84,784	81,206
Cash paid during the year for: Income taxes	0	0
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
Transfer of inventory to leased equipment	449,951	373,891
Series V Notes issued for consulting services	0	25,000
Accrued interest added to principle of promissory note - related party	0	263,027
Conversion of advances from related party to promissory notes	1,789,006	0
In-Kind payments by investors for Series notes	$ 140,000	$ 0

Subsequent Events (Details Text

Subsequent Events (Details Textual) - USD ($)	Nov. 01, 2017	Oct. 02, 2017	Oct. 31, 2017	Oct. 30, 2017	Sep. 30, 2017	Jun. 30, 2017	Sep. 30, 2017	Mar. 31, 2017	Dec. 31, 2016
Subsequent Event [Line Items]
Common Stock, par value (in dollars per share)					$ 0.0001		$ 0.0001		$ 0.0001
Preferred Stock, Shares Authorized					10,000,000		10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share					$ 0.0001		$ 0.0001		$ 0.0001
Series A Preferred Stock [Member] | Share-based Compensation Award, Tranche Two [Member]
Subsequent Event [Line Items]
Proceeds from Issuance or Sale of Equity			$ 900,300
Shareholder Awareness Consulting Agreement [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Issued for Services					40,116	34,884
Share Price					$ 3		3
Convertible Debt [Member]
Subsequent Event [Line Items]
Share Price					$ 4		$ 4	$ 2.954
Common Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Issued for Services							133,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 5
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right				333,401
Subsequent Event [Member] | Share-based Compensation Award, Tranche Two [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			200,067
Subsequent Event [Member] | Series A Preferred Stock [Member]
Subsequent Event [Line Items]
Common Stock, par value (in dollars per share)				$ 0.0001
Preferred Stock, Shares Authorized				333,401
Preferred Stock, Par or Stated Value Per Share				$ 0.0001
Stock Issued During Period, Value, New Issues				$ 1,500,300
Preferred Stock, Amount Authorized				$ 1,667,000
Convertible Preferred Stock, Conversion Price				$ 5
Stockholders' Equity Note, Stock Split				1 for 1 basis
Convertible Preferred Stock, Terms of Conversion				The conversion rate is subject to adjustment for stock splits, reclassification and issuance of certain Securities at a purchase price per share below the conversion price. The Series A Shares will automatically convert into Common Stock if the Company (i) receives gross proceeds of $6,000,000 or (ii) receives gross proceeds sufficient to qualify for listing on a natural securities exchange. If the Company completes a financing at a price per share of less than $5.00, one-half of the Series A Shares will convert at a conversion price equal to the purchase price of such financing. The Series A Shares are entitled to receive dividends, payable quarterly commencing December 31, 2017, at the rate of five percent (5%) during the first year of issuance, and increasing two percent (2%) per month thereafter. The Series A Shares rank senior to the Company’s Common Stock with respect to dividends, distributions and payments on liquidation. The Registrant also has the right to redeem the Series A Shares one year after the First Closing for 120% of the stated value plus any unpaid dividends. Commencing on June 1, 2019, the Investor will have the right to require the Company to redeem the Series A Shares for 115% of the Conversion Amount, under certain circumstances.
Subsequent Event [Member] | Series A Preferred Stock [Member] | Share-based Compensation Award, Tranche One [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues			133,334
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			133,334
Proceeds from Issuance or Sale of Equity			$ 600,000
Subsequent Event [Member] | Series A Preferred Stock [Member] | Share-based Compensation Award, Tranche Two [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues			200,067
Subsequent Event [Member] | Shareholder Awareness Consulting Agreement [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		10,000
Payments for Other Fees		$ 90,000
Stock Issued During Period, Shares, Issued for Services		35,000
Share Price		$ 5
Subsequent Event [Member] | Entsorgafin S.p.A [Member] | Intellectual Property [Member]
Subsequent Event [Line Items]
Common Stock, par value (in dollars per share)	$ 0.0001
Stock Issued During Period, Shares, New Issues	1,035,905
Royalty Guarantees, Commitments, Amount	$ 6,019,200
Payments for Royalties	$ 839,678.40
Subsequent Event [Member] | Convertible Debt [Member]
Subsequent Event [Line Items]
Debt Conversion, Original Debt, Amount			$ 110,000
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued			40,454